Show Summary Details
Page of

Autoimmune rheumatic disorders and vasculitis in pregnancy 

Autoimmune rheumatic disorders and vasculitis in pregnancy

Chapter:
Autoimmune rheumatic disorders and vasculitis in pregnancy
Author(s):

May Ching Soh

, Kate Bramham

, Sarah Germain

, and Catherine Nelson-Piercy

DOI:
10.1093/med/9780199204854.003.1414_update_002

Update:

Disease-modifying drugs in pregnancy and breastfeeding—updated information.

Antiphospholipid syndrome—discussion of use of low-dose prednisolone to prevent pregnancy losses.

Rheumatoid arthritis—comments on (1) use of rituximab in pregnancy; (2) vaccination after use of anti-TNFα‎ agents in pregnancy.

Scleroderma—expanded notes on effect of scleroderma on pregnancy.

Updated on 28 Nov 2012. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 19 August 2017

Autoimmune diseases affect 5 to 7% of people, are commoner in women of childbearing age, and are frequently encountered in pregnancy. They may remit or improve during pregnancy, but can flare or present in pregnancy with disastrous consequences. The postpartum period is a time of susceptibility to autoimmune disorders, and women who already have an autoimmune disorder may suffer disease exacerbation following pregnancy....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.